+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosurgery Market - Global Forecast 2026-2032- Product Image
Biosurgery Market - Global Forecast 2026-2032- Product Image
New

Biosurgery Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082626
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biosurgery market is evolving rapidly, driven by continuous advancements in biomaterials, digital technologies, and surgical methods. This dynamic environment requires senior leaders to both anticipate and respond to shifting industry drivers and new technology adoption.

Market Snapshot: Biosurgery Market Size, Growth, and Future Outlook

The biosurgery market has demonstrated significant momentum, increasing from USD 18.58 billion in 2025 to USD 20.14 billion in 2026. With a projected compound annual growth rate (CAGR) of 8.75%, the market is expected to reach USD 33.43 billion by 2032. This strong growth trajectory highlights robust global healthcare demand, ongoing technological innovation, and expanding regional investment. As biosurgery becomes integral to optimized surgical outcomes, its influence now spans multiple clinical specialties and geographies, offering substantial opportunity for forward-thinking organizations.

Biosurgery Market Scope & Segmentation

This report offers a detailed analysis of the evolving biosurgery industry, examining the clinical, technological, material, and end-user elements shaping growth and adoption. Critical segmentation and innovation trends include:

  • Product Types: Hemostats, sealants, adhesives, and graft materials each enable specific procedural outcomes, such as bleeding control, tissue adhesion, enhanced healing, and fluid management across diverse surgical interventions.
  • Material Innovations: Collagen-based, fibrin-based, gelatin-based, and synthetic materials deliver performance benefits around adaptability, patient safety, and compatibility with both open and minimally invasive surgeries.
  • Resorbability Profiles: Nonresorbable, fully resorbable, and partially resorbable products are tailored for different procedural needs and patient risk profiles—addressing both support requirements and preferences for minimizing long-term implant presence.
  • Clinical Applications: Solutions address cardiovascular, general, orthopedic, dental, and ophthalmic surgeries, enabling procedure-specific efficiencies and improved patient outcomes across specialty disciplines.
  • End User Environments: Hospitals, ambulatory surgery centers, and specialty clinics each adopt biosurgery technologies with unique procurement processes, reflecting the complexity and volume of surgical procedures handled.
  • Regional Coverage: Analysis spans the Americas, Europe, Middle East and Africa, and Asia Pacific, examining adoption triggers, policy environments, and new opportunities tailored to regional market maturity and infrastructure.
  • Technological Innovations: Emerging approaches such as regenerative medicine, digital tools—including AI-driven surgical planning and robotics—and advanced delivery systems enhance procedural precision, safety, and integration into clinical workflows.

Key Takeaways for Senior Leaders

  • Innovation across biomaterials and surgical delivery platforms is systematically redefining how procedures are performed and integrated within healthcare settings.
  • AI and robotics are broadening the capabilities of surgical teams, facilitating real-time monitoring, data analytics, and more personalized procedural approaches.
  • Expanding use of minimally invasive techniques calls for solutions compatible with evolving surgical standards and technologies, presenting new priorities for product development and clinician training.
  • Procurement approaches differ widely: hospitals tend to prioritize comprehensive solutions and established vendors, while ambulatory centers and specialty clinics often seek flexibility in features and partnerships.
  • Regional distinctions in regulation, reimbursement policy, and healthcare capacity shape product adoption and influence supplier strategies in each market.
  • Collaboration among leading manufacturers, startups, and academic partners is accelerating the pace of product innovation and market access for novel biosurgery technologies.

Tariff Impact: United States Supply Chain and Sourcing Strategies

New United States import tariffs introduced in 2025 have significantly changed the cost profile for key biosurgery components. In response, manufacturers are adjusting supply chain strategies, often absorbing increased duties and exploring domestic sourcing to enhance operational efficiency. Distributors and end users are adapting procurement tactics—balancing stable pricing with dynamic trade schedules. The industry is also increasing investment in regional manufacturing hubs to optimize logistics, reduce tariff-related costs, and develop resilient supply chains closer to demand centers.

Biosurgery Market Methodology & Data Sources

This analysis incorporates comprehensive primary and secondary research, drawing on executive and clinical expert interviews as well as peer-reviewed publications and regulatory findings. Validation occurred through expert panels and competitive benchmarking, ensuring all insights are both actionable and credible for executive decision-making.

Why This Report Matters to Decision-Makers

  • Highlights where clinical needs overlap with the latest industry innovation, supporting effective resource and investment allocation in priority market segments.
  • Clarifies the implications of regulatory shifts, supply chain risk, and regional policy, equipping leaders to navigate procurement and market entry confidently.
  • Delivers a clear view of trends and segmentation, empowering commercial and medical teams to deploy tailored go-to-market strategies and build impactful partnerships.

Conclusion

Effective engagement in the biosurgery market depends on data-driven strategies, agility in adapting to technology, and collaborative investment. This report supports senior leaders in aligning innovation with growth, advancing patient outcomes across global healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biosurgery Market, by Product Type
8.1. Hemostats
8.2. Sealants & Adhesives
8.3. Tissue Grafts
9. Biosurgery Market, by Material Type
9.1. Collagen-Based
9.2. Fibrin-Based
9.3. Gelatin-Based
9.4. Synthetic
10. Biosurgery Market, by Resorbability
10.1. Nonresorbable
10.2. Resorbable
10.2.1. Fully Resorbable
10.2.2. Partially Resorbable
11. Biosurgery Market, by Application
11.1. Cardiovascular Surgery
11.1.1. Bypass Surgery
11.1.2. Valve Repair
11.2. General Surgery
11.2.1. Hernia Repair
11.2.2. Wound Repair
11.3. Minimally Invasive Surgery
11.3.1. Endoscopic
11.3.2. Laparoscopic
11.4. Open Surgery
11.5. Orthopedic Surgery
11.5.1. Joint Replacement
11.5.2. Spinal Fusion
12. Biosurgery Market, by End User
12.1. Ambulatory Surgery Centers
12.2. Hospitals
12.3. Specialty Clinics
12.3.1. Dental Clinics
12.3.2. Ophthalmology Clinics
13. Biosurgery Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biosurgery Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biosurgery Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biosurgery Market
17. China Biosurgery Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Advanced Medical Solutions Group plc
18.6. Artivion, Inc.
18.7. B. Braun Melsungen AG
18.8. Baxter International Inc.
18.9. Becton, Dickinson and Company
18.10. BioCer Entwicklungs-GmbH
18.11. Boston Scientific Corporation
18.12. Cardinal Health, Inc.
18.13. Corza Medical GmbH
18.14. CryoLife, Inc.
18.15. CSL Limited
18.16. Hemostasis, LLC
18.17. Integra LifeSciences Holdings Corporation
18.18. Johnson & Johnson
18.19. Kuros Bioscience AG
18.20. Medtronic plc
18.21. Pfizer Inc.
18.22. RTI Surgical, Inc.
18.23. Samyang Holdings Corporation
18.24. Sanofi SA
18.25. Smith & Nephew plc
18.26. Stryker Corporation
18.27. Teleflex Incorporated
18.28. Tissue Regenix Ltd
18.29. Vivostat A/S
List of Figures
FIGURE 1. GLOBAL BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS & ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS & ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS & ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY NONRESORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOSURGERY MARKET SIZE, BY NONRESORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOSURGERY MARKET SIZE, BY NONRESORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOSURGERY MARKET SIZE, BY FULLY RESORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOSURGERY MARKET SIZE, BY FULLY RESORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOSURGERY MARKET SIZE, BY FULLY RESORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOSURGERY MARKET SIZE, BY PARTIALLY RESORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOSURGERY MARKET SIZE, BY PARTIALLY RESORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOSURGERY MARKET SIZE, BY PARTIALLY RESORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOSURGERY MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOSURGERY MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOSURGERY MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOSURGERY MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOSURGERY MARKET SIZE, BY VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOSURGERY MARKET SIZE, BY VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOSURGERY MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOSURGERY MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOSURGERY MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND REPAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND REPAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOSURGERY MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOSURGERY MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOSURGERY MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOSURGERY MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOSURGERY MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOSURGERY MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOSURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOSURGERY MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOSURGERY MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOSURGERY MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOSURGERY MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOSURGERY MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOSURGERY MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOSURGERY MARKET SIZE, BY SPINAL FUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOSURGERY MARKET SIZE, BY SPINAL FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOSURGERY MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOSURGERY MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOSURGERY MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOSURGERY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOSURGERY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOSURGERY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS BIOSURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 176. AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 177. AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 178. AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 180. AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 181. AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL BIOSURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASEAN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 201. ASEAN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. ASEAN BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 206. ASEAN BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 207. ASEAN BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. ASEAN BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 210. GCC BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GCC BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. GCC BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 213. GCC BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 214. GCC BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 215. GCC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. GCC BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 217. GCC BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 218. GCC BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 219. GCC BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 220. GCC BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. GCC BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 234. BRICS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 237. BRICS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 238. BRICS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 239. BRICS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. BRICS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 241. BRICS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 242. BRICS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 243. BRICS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 244. BRICS BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. BRICS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 246. G7 BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. G7 BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. G7 BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 249. G7 BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 250. G7 BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 251. G7 BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. G7 BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 253. G7 BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 254. G7 BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 255. G7 BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 256. G7 BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. G7 BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 258. NATO BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. NATO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 260. NATO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 261. NATO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 262. NATO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 263. NATO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. NATO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 265. NATO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 266. NATO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 267. NATO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 268. NATO BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. NATO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 283. CHINA BIOSURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. CHINA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 286. CHINA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2032 (USD MILLION)
TABLE 287. CHINA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2032 (USD MILLION)
TABLE 288. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. CHINA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
TABLE 290. CHINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
TABLE 291. CHINA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2032 (USD MILLION)
TABLE 292. CHINA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
TABLE 293. CHINA BIOSURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. CHINA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biosurgery market report include:
  • Advanced Medical Solutions Group plc
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Corza Medical GmbH
  • CryoLife, Inc.
  • CSL Limited
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Bioscience AG
  • Medtronic plc
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Tissue Regenix Ltd
  • Vivostat A/S

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 20.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.43 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Biosurgery Market Report by Product, Source, Application, End User, and Region 2025-2033 - Product Image

Biosurgery Market Report by Product, Source, Application, End User, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030 - Product Image

Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030

  • Report
  • 414 Pages
  • Global
From
Biosurgery - Global Strategic Business Report - Product Image

Biosurgery - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Biosurgery Market Report 2025 - Product Image

Biosurgery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biosurgery Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Biosurgery Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 122 Pages
  • Global
From

About the Biosurgery Market

Biosurgery is a rapidly growing field of medical technology that focuses on the use of biological materials to repair, replace, or supplement damaged or missing tissue. It is used in a variety of surgical procedures, including reconstructive surgery, orthopedic surgery, and plastic surgery. Biosurgery products are designed to provide a more natural and effective solution to tissue repair and regeneration. These products are often made from biocompatible materials, such as collagen, hyaluronic acid, and other proteins, and are designed to be minimally invasive and to reduce the risk of infection. Biosurgery products are used in a variety of surgical procedures, including wound healing, tissue engineering, and regenerative medicine. They are also used to treat a variety of conditions, such as burns, ulcers, and hernias. Biosurgery products are also used in cosmetic surgery, such as breast augmentation and facial reconstruction. Some of the companies in the biosurgery market include Allergan, Baxter, Bausch Health, Covidien, Johnson & Johnson, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.